查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1870130

人工心臟市場按類型、應用、技術、最終用戶和病患小組分類－2025-2032年全球預測

Artificial Heart Market by Type, Application, Technology, End User, Patient Group - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工心臟市場將成長至 68.1 億美元，複合年成長率為 11.64%。

關鍵市場統計數據
基準年 2024 28.2億美元
預計年份：2025年 31.4億美元
預測年份 2032 68.1億美元
複合年成長率 (%) 11.64%

透過分析臨床需求、技術創新軌跡、監管複雜性和支付方考量，梳理不斷發展的人工心臟格局，從而指導醫療保健相關人員的策略決策。

人工心臟領域正處於嚴峻的臨床需求、技術創新和複雜的監管三者交匯的境地。近年來，設備耐用性、小型化和遠端監測方面的進步，使這項技術從實驗性治療發展成為適用於特定患者群體的實用長期機械循環支援手段。同時，臨床醫生和醫療系統也面臨著不斷更新的臨床指南、日益重視的感染控制和抗凝血管理，以及透過療效和成本效益指標來證明其價值的日益成長的壓力。

識別正在重塑人工心臟發展的變革性轉變，包括小型化、耐用的機械循環支援平台、數位化整合以及新型生物相容性材料，這些轉變將推動人工心臟的臨床效用。

多項變革正在重塑人工心臟生態系統，創造新的機遇，同時也重塑競爭格局。首先，小型化和能源效率的技術進步使得人工心臟能夠實現更小的外形規格和門診使用，從而擴大了其適應症範圍並改變了移植物流。同時，生物相容性塗層和血液相容性的提高降低了血栓風險和感染相關併發症，改變了人們對長期管理的預期和追蹤通訊協定。

評估美國關稅對人工心臟供應鏈、採購趨勢、臨床准入途徑以及製造商和供應商的策略性定價應對措施的累積影響

2025年美國關稅的實施和貿易政策的轉變將對人工心臟的供應鏈、籌資策略和臨床應用模式產生多方面的影響。關稅將增加許多先進設備製造商所依賴的進口零件和子組件的到岸成本，尤其是專用感測器、電機用稀土元素材料以及從國外採購的精密加工零件。直接影響將迫使製造商重新評估其供應商組合，加快國內供應商的資格認證，或調整內部利潤率以消化增加的成本。

透過識別設備類型、應用、技術、最終用戶和患者群體等不同細分市場中可操作的洞察，指南產品設計、臨床應用和市場推廣策略。

詳細的市場區隔分析明確了臨床需求、技術能力和商業性機會的交會點。基於類型的市場分析區分了全人工心臟和心室輔助裝置，心室輔助裝置類別進一步細分為雙心室輔助裝置、左心室輔助裝置和右心室輔助裝置，以反映不同的臨床適應症和植入複雜性。每種裝置亞型都有其獨特的設計權衡、後續要求和臨床培訓計劃，這些因素共同影響臨床實踐中的應用模式。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 具有無線能量傳輸能力的全植入式人工心臟的應用日益普及
  • 可生物分解的人工心臟支架促進組織再生
  • 用於即時監測機械心臟性能的感測器整合技術取得了進展
  • 新一代有血流控制功能的兒童人工心臟的臨床試驗正在增加
  • 生技公司與學術機構合作，利用基因編輯技術開發心肌支援裝置
  • 攜帶式人工心臟系統的監管核准增加，使得居家照護成為可能。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 人工心臟市場（按類型分類）

  • 人工心臟
  • 心室輔助裝置
    • 雙心室輔助裝置
    • 左心室輔助裝置
    • 右心室輔助裝置

第9章 按應用分類的人工心臟市場

  • 移植橋樑
  • 最終治療

第10章 按技術分類的人工心臟市場

  • 軸流式
  • 離心式
  • 電磁
  • 氣動

第11章 人工心臟市場（依終端用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第12章：依病患小組的人工心臟市場

  • 成人
  • 兒童

第13章：人工心臟市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 人工心臟市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國人工心臟市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abiomed, Inc.
    • Abbott Laboratories
    • Medtronic plc
    • SynCardia Systems, LLC
    • Carmat SA
    • Berlin Heart GmbH
    • Jarvik Heart, Inc.
    • BiVACOR, Inc.
    • Sun Medical Technology R&D Co., Ltd.
    • ReliantHeart, Inc.
Product Code: MRR-3204321AF691

The Artificial Heart Market is projected to grow by USD 6.81 billion at a CAGR of 11.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.82 billion
Estimated Year [2025] USD 3.14 billion
Forecast Year [2032] USD 6.81 billion
CAGR (%) 11.64%

Framing the evolving artificial heart landscape through clinical demand, innovation trajectories, regulatory complexities and payer considerations to orient strategic decision-making across healthcare stakeholders

The artificial heart landscape sits at the intersection of acute clinical need, engineering innovation and complex regulatory oversight. Recent advances in device durability, miniaturization and remote monitoring have elevated the technology from experimental therapy toward viable long-term mechanical circulatory support for selected patient populations. At the same time, clinicians and health systems face evolving clinical guidelines, intensified focus on infection control and anticoagulation management, and mounting pressure to demonstrate value through outcomes and cost-effectiveness metrics.

This introduction synthesizes the key forces shaping device development and clinical adoption, framing how improvements in biocompatible materials, power management and digital telemetry are unlocking new care pathways. It establishes the context for strategic decision-making by manufacturers, hospital procurement teams and clinical leaders, emphasizing the need for integrated planning across R&D, regulatory strategy and health economics. By highlighting the prevailing clinical imperatives and the technological enablers that respond to them, this section sets the stage for deeper analysis of market dynamics, segmentation drivers and region-specific considerations that follow.

Identifying transformative shifts reshaping artificial heart development including miniaturization, durable mechanical circulatory support platforms, digital integration and novel biocompatible materials driving clinical utility

Several transformative shifts are redefining the artificial heart ecosystem, creating new opportunities while resetting competitive imperatives. First, engineering advances in miniaturization and power efficiency are enabling smaller form factors and ambulatory use, which in turn broaden candidate profiles and alter implantation logistics. Concurrently, improvements in biocompatible coatings and hemocompatibility have reduced thrombotic risk and infection-related complications, changing long-term management expectations and follow-up protocols.

Digital integration is another pivotal trend: the embedding of telemetry, remote monitoring and predictive analytics into device platforms supports proactive clinical interventions, reduces readmissions and enables data-driven value demonstrations to payers. On the regulatory front, accelerated approval pathways and more harmonized international standards are shortening time-to-clinic for incremental device updates, even as scrutiny around safety and post-market surveillance intensifies. Finally, the convergence of novel financing models, growing private capital interest and strategic partnerships between device specialists and broader medtech or technology firms is reshaping product roadmaps and commercialization strategies. Together, these shifts are transitioning artificial heart technologies from niche salvage therapies to increasingly mainstream options within complex heart-failure care pathways.

Assessing cumulative impact of United States tariffs on the artificial heart supply chain, procurement dynamics, clinical access pathways and strategic pricing responses by manufacturers and providers

The imposition of tariffs and trade policy shifts in the United States in 2025 has a multi-dimensional effect on the artificial heart supply chain, procurement strategies and clinical access models. Tariffs increase the landed cost of imported components and subassemblies that many advanced device manufacturers rely upon, particularly when specialized sensors, rare-earth materials for motors, or precision machining are sourced internationally. The immediate consequence is pressure on manufacturers to reassess supplier portfolios, accelerate qualification of domestic vendors, or absorb cost increases through internal margin adjustments.

Hospitals and ambulatory surgical centers respond to higher device acquisition costs by seeking stronger value propositions, longer device longevity assurances, bundled service contracts, and clearer evidence of reduced downstream utilization. Payers meanwhile intensify scrutiny of reimbursement pathways and may require more robust real-world outcomes data to justify higher payments. To preserve competitiveness, device developers pursue a combination of strategies including supplier diversification, localizing critical manufacturing steps, redesigning products to reduce cost-sensitive inputs, and negotiating longer-term supply agreements to hedge volatility.

Regulatory and procurement teams must also account for potential lead-time variability and customs-related delays; this amplifies the importance of inventory planning and contingency sourcing. In aggregate, tariffs act as a catalyst for deeper supply chain resilience planning and may accelerate strategic moves toward regional manufacturing hubs, without fundamentally altering the clinical rationale for mechanical circulatory support.

Delineating actionable segmentation insights across device type, application, technology, end users and patient demographics to inform product design, clinical adoption and go-to-market strategies

A granular segmentation lens clarifies where clinical need, technology capability and commercial opportunity align. Based on Type, market analysis differentiates between Total Artificial Heart and Ventricular Assist Device, with the Ventricular Assist Device category further subdivided into Biventricular Assist Device, Left Ventricular Assist Device, and Right Ventricular Assist Device to reflect differing clinical indications and implantation complexity. Each device subtype entails distinct engineering trade-offs, follow-up requirements and clinical training programs, which shape adoption patterns across care settings.

Based on Application, the distinction between Bridge To Transplant and Destination Therapy highlights divergent evidence expectations: Bridge To Transplant usage relies heavily on short-to-intermediate term reliability and compatibility with transplant pathways, whereas Destination Therapy demands long-term durability and quality-of-life metrics. Based on Technology, axial, centrifugal, electromagnetic and pneumatic platforms each present unique profiles in terms of hemocompatibility, power consumption and implant footprint, informing which patient populations and clinical scenarios they best serve. Based on End User, the variance among Ambulatory Surgical Centers, Hospitals and Specialty Clinics affects procedural throughput, perioperative staffing models and capital acquisition decisions. Finally, Based on Patient Group, differences between Adults and Pediatrics require tailored device sizing, physiological considerations and specialized clinical protocols. When integrated, these segmentation dimensions guide prioritized product development, targeted clinical trials and differentiated commercial strategies.

Uncovering critical regional considerations across the Americas, Europe Middle East and Africa, and Asia Pacific to align regulatory pathways, reimbursement models and commercialization plans

Regional dynamics materially influence regulatory timelines, reimbursement approaches and clinical uptake. In the Americas, concentrated centers of excellence, established transplant programs and mature hospital procurement processes create fertile ground for high-cost, high-complexity devices, while regional payers increasingly demand robust outcomes evidence to authorize reimbursement. North American clinical networks also tend to drive innovation adoption when led by influential academic centers, and procurement-led group purchasing can accelerate scale deployment across health systems.

In Europe, Middle East & Africa, regulatory fragmentation and heterogeneous reimbursement models shape a more phased adoption curve, with leading national health systems often piloting new technologies before broader roll-out. Reimbursement in several European markets hinges on health technology assessment outcomes and negotiation with national payers, which emphasizes the need for early engagement and real-world data generation. Regionally, countries in the Middle East and Africa present divergent infrastructure readiness and financing mechanisms, necessitating tailored market-entry strategies.

Across Asia-Pacific, rapid expansion of specialized cardiac centers, growing domestic medtech capabilities, and diverse payer landscapes create both competitive pressure and partnership opportunities. Several markets in the region favor local manufacturing partnerships and technology transfer agreements to support scale, while others prioritize fast regulatory pathways for devices addressing significant unmet clinical need. Recognizing these regional contrasts allows stakeholders to sequence market entry, evidence generation and commercial investments to maximize clinical impact and return on effort.

Highlighting competitive and collaborative company-level developments, strategic partnerships, IP trajectories, and investment patterns shaping leadership in the artificial heart ecosystem

Company-level activity in the artificial heart domain is characterized by a dual track of sustained investment from established medical device manufacturers and nimble innovation from specialized startups and academic spin-outs. Incumbent firms typically focus on incremental improvements to enhance reliability, reduce adverse events, and expand indications through clinical studies. Meanwhile, smaller companies and university-affiliated teams often pursue disruptive concepts-novel pump architectures, alternative energy transfer mechanisms, or biomaterials that minimize host response-which can become attractive targets for strategic partnerships or licensing deals.

Strategic collaborations are a recurring theme: clinical partnerships accelerate access to real-world data, contract manufacturing and supply chain alliances mitigate production risk, and co-development agreements with technology companies enhance telemetry and analytics capabilities. Intellectual property strategies, including targeted patenting and defensive portfolios, differentiate market positioning and influence M&A activity. Investment patterns show growing interest in platform technologies that enable modular upgrades, as well as services that bundle device provision with remote monitoring and outcomes management. Competitive advantage increasingly depends on integrated solutions that combine device performance with ecosystem services, regulatory acumen and scalable manufacturing.

Presenting actionable recommendations for device manufacturers, clinical leaders and payers to accelerate adoption, optimize value propositions and mitigate supply chain and regulatory friction

Industry leaders can take several pragmatic actions to accelerate adoption and safeguard commercial momentum. Manufacturers should prioritize modular design principles that reduce dependence on tariff-sensitive components and simplify regulatory submissions for incremental improvements. Establishing validated secondary suppliers and qualifying local manufacturing partners will reduce exposure to supply chain shocks while preserving time-to-market. Concurrently, investing in telemetry and outcomes platforms creates defensible differentiation by generating the real-world evidence payers and health systems increasingly require.

Clinical leaders should codify standardized implantation and follow-up pathways that capture consistent patient-reported and clinical outcomes, enabling comparative effectiveness assessments and supporting reimbursement discussions. Early engagement with payers to define value metrics, bundled payment options, and risk-sharing arrangements will facilitate smoother adoption. Payers and hospital systems should pilot payment models that align reimbursement with demonstrated reductions in readmissions, length of stay and downstream interventions, while ensuring patient access for high-need cohorts.

Across the ecosystem, stakeholders should collaborate on registries and cross-institutional data-sharing initiatives to accelerate evidence generation. A coordinated approach to regulatory strategy, supply chain resilience and value demonstration will materially increase the probability of sustained clinical adoption and commercial success.

Describing a rigorous mixed-methods research methodology blending clinical evidence appraisal, stakeholder interviews, supply chain analysis and regulatory mapping to ensure robust market intelligence

This research deploys a mixed-methods methodology designed to triangulate clinical, commercial and regulatory perspectives and produce robust, actionable intelligence. The approach begins with a comprehensive appraisal of peer-reviewed clinical literature, regulatory filings and published guidance to establish the evidence base for device safety, efficacy and indications. That foundation is complemented by structured interviews with a representative sample of stakeholders including cardiothoracic surgeons, heart failure specialists, hospital procurement leaders, payers and device engineers to capture experiential insight and operational constraints.

Supply chain analysis maps critical component flows, manufacturing dependencies and potential chokepoints, while regulatory mapping compares approval and post-market surveillance expectations across major jurisdictions. Where available, anonymized real-world data and registry summaries inform assessments of utilization patterns and outcomes. Findings are validated through cross-checks with industry experts and methodical reconciliation of qualitative and quantitative inputs. Throughout the process, emphasis is placed on transparency of assumptions, reproducibility of findings and clear articulation of limitations to ensure that end-users can confidently apply insights to strategic decisions.

Concluding insights that synthesize technological, regulatory and commercial trajectories to guide strategic decision-making and future investment priorities within the artificial heart domain

The convergence of technological maturation, evolving clinical protocols and shifting commercial dynamics positions artificial heart technologies at an inflection point. Advances in device engineering and telemetry are steadily reducing traditional barriers to broader adoption, while regional regulatory and reimbursement environments continue to shape the pace and pattern of uptake. Supply chain pressures and trade policy changes add complexity that organizations must proactively manage through diversification and near-term operational planning.

Strategically, the most successful stakeholders will be those that integrate product innovation with comprehensive evidence generation, resilient manufacturing strategies and payer-aligned value propositions. Collaboration across clinical, engineering and commercial teams will accelerate the translation of laboratory progress into clinical best practice. As devices become more embedded within longitudinal care models, the ability to demonstrate meaningful improvements in patient-centered outcomes and system-level efficiencies will determine which technologies achieve durable adoption and scale. This synthesis underscores the need for deliberate, data-driven action to realize the transformative potential of artificial heart solutions across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of fully implantable total artificial hearts with wireless energy transfer
  • 5.2. Emergence of biodegradable artificial heart scaffolds enhancing natural tissue regeneration
  • 5.3. Advancements in sensor integration for real time monitoring of mechanical heart performance
  • 5.4. Growing clinical trials of next generation pediatric artificial hearts with adjustable flow rates
  • 5.5. Collaborations between biotech firms and academic institutions for gene edited myocardial support devices
  • 5.6. Increasing regulatory approvals for portable artificial heart ambulatory systems enabling home based care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Heart Market, by Type

  • 8.1. Total Artificial Heart
  • 8.2. Ventricular Assist Device
    • 8.2.1. Biventricular Assist Device
    • 8.2.2. Left Ventricular Assist Device
    • 8.2.3. Right Ventricular Assist Device

9. Artificial Heart Market, by Application

  • 9.1. Bridge To Transplant
  • 9.2. Destination Therapy

10. Artificial Heart Market, by Technology

  • 10.1. Axial
  • 10.2. Centrifugal
  • 10.3. Electromagnetic
  • 10.4. Pneumatic

11. Artificial Heart Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Artificial Heart Market, by Patient Group

  • 12.1. Adults
  • 12.2. Pediatrics

13. Artificial Heart Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Artificial Heart Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Artificial Heart Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abiomed, Inc.
    • 16.3.2. Abbott Laboratories
    • 16.3.3. Medtronic plc
    • 16.3.4. SynCardia Systems, LLC
    • 16.3.5. Carmat SA
    • 16.3.6. Berlin Heart GmbH
    • 16.3.7. Jarvik Heart, Inc.
    • 16.3.8. BiVACOR, Inc.
    • 16.3.9. Sun Medical Technology R&D Co., Ltd.
    • 16.3.10. ReliantHeart, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL HEART MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ARTIFICIAL HEART MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ARTIFICIAL HEART MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL HEART MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL HEART MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL HEART MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GCC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GCC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GCC ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GCC ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 248. GCC ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 249. GCC ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. GCC ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. GCC ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. GCC ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. GCC ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. GCC ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. GCC ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GCC ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. BRICS ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. BRICS ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 276. BRICS ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 277. BRICS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. BRICS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. BRICS ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. BRICS ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. BRICS ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. BRICS ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. G7 ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. G7 ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. G7 ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. G7 ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. G7 ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 290. G7 ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 291. G7 ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. G7 ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. G7 ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. G7 ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. G7 ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. G7 ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. G7 ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. G7 ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. NATO ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. NATO ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. NATO ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. NATO ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. NATO ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 304. NATO ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 305. NATO ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. NATO ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. NATO ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. NATO ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. NATO ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. NATO ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. NATO ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. NATO ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 323. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 327. CANADA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. CANADA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. CANADA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 330. CANADA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 331. CANADA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. CANADA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. CANADA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. CANADA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. CANADA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. CANADA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 337. CANADA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 338. CANADA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025-2032 (USD MILLION)
  • TABLE 339. MEXICO ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. MEXICO ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. MEXICO ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 342. MEXICO ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 343. MEXICO ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 344. MEXICO ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 345. MEXICO ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 346. MEXICO ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 347. MEXICO ARTIFICIAL HEART MARKET S